Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1998 Dec 7;11(2):78–81. doi: 10.1002/(SICI)1098-2825(1997)11:2<78::AID-JCLA2>3.0.CO;2-G

Reliability of four methods for the diagnosis of acute infection by Epstein‐Barr virus

J Gutiérrez 1,✉, M Rodríguez 1, C Maroto 1, G Piédrola 1
PMCID: PMC6760749  PMID: 9058240

Abstract

We studied the reliability of new indirect tests in the diagnosis of acute infection by Epstein‐Barr virus (EBV). Studied for all samples were: method 1, the heterophil antibodies (Abs) (Monolatex, Biokit, Germany); method 2, the IgM Abs to EBV with ELISA tests (antigen pools, Enzygnost, Behringwerke, Germany); method 3, EA (Biotest Diagnostics, Germany); and method 4, the IgG avidity test. The reliability of the four tests for the detection of primary infection by EBV was: sensitivity (method 1:89.1%; method 2: 100%; method 3: 79.7%; method 4: 99%); specificity (method 1: 98%; method 2: 100%; method 3:84%; method 4: 100%); positive predictive value (method 1: 97.6%; method 2: 100%; method 3: 73.6%; method 4: 100% method 4: 100%), and negative predictive value (method 1: 90.7%; method 2: 100%; method 3:84%; method 4: 99%). The IgG avidity test (method 4) is simple and automated in the laboratory and is very useful for ascertaining, from a single sample, the time since infection. It is criteria of recent primoinfection higher levels than 55% of IgG with low avidity for the antigen. The investigation of the Abs to antigen pools (method 2) by ELISA of virus had a high reliability, but the investigation of heterophil Abs by latex (method 1) and the Abs IgM to EA (method 2) were lacking in sensibility regarding their use in the diagnosis of the primoinfection. J. Clin. Lab. Anal. 11:78–81. © 1997 Wiley‐Liss, Inc.

Keywords: Epstein‐Barr virus, cytomegalovirus, herpes simple virus, IgG, IgM

References

  • 1. Andersson J, Skoldenberg B, Henle W, Giesecke J, Ortqvist A, Julander I, Gustavsson E, Akerlund B, Britton S, Ernberg I: Acyclovir treatment in infectious mononucleosis: A clinical and virological study. Infection 15(Suppll): S14–20, 1987. [DOI] [PubMed] [Google Scholar]
  • 2. Steeper TA, Horwitz CA, Moore SB, Henle W, Henle G, Ellis R, Flynn PJ: Severe thrombocytopenia in Epstein‐Barr virus‐induced mononucleosis. West J Med 150: 170–173, 1989. [PMC free article] [PubMed] [Google Scholar]
  • 3. De Ory F. Viral infections: Interpretation of specific IgM detection assays. Spanish J Microbiol Clin 25: 110–112, 1991. [Google Scholar]
  • 4. Grazia M, Percivalle E, Zannini M, Rossi V, Gerna G: Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein. J Virol Methods 35: 315–329, 1991. [DOI] [PubMed] [Google Scholar]
  • 5. De Ory F, Antonaya J, Fernández V, Echevarría JM: Application of lowavidity immunoglobulin G studies to diagnosis of Epstein‐Barr virus infectious mononucleosis. J Clin Microbiol 31: 1669–1671, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. De Ory F, Casa I, Domingo CJ, Echevarría JM: Application of fluoroimmunoassay to identification of low avidity specific IgG against pathogenic human viruses and Toxoplasma gondii . Clin Diag Virol 3: 323–335, 1995. [DOI] [PubMed] [Google Scholar]
  • 7. Ward KN, Gray JJ, Fotheringham MW, Sheldon MJ: IgG antibodies to human herpesvirus‐6 in young children: Changes in avidity of antibody correlate with time after infection. J Med Virol 39: 131–138, 1993. [DOI] [PubMed] [Google Scholar]
  • 8. Ward KN, Gray JJ, Joslin ME, Sheldon MJ: Avidity of IgG antibodies to human Herpesvirus‐6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross‐reactivity with other Herpesvirus. J Med Virol 39: 44–49, 1993. [DOI] [PubMed] [Google Scholar]
  • 9. Fikar CR, McKee MD: False positivity of IgM antibody to Epstein‐Barr viral capsid antigen during acute hepatitis a infection. Pediatric Infect Dis J 13: 413–414, 1994. [DOI] [PubMed] [Google Scholar]
  • 10. Hedman K, Lappalainen M, Söderlund M, Hedman L: Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 4: 123–129, 1993. [Google Scholar]
  • 11. Gray JJ, Caldwell J, Sillis M: The rapid serological diagnosis of infectious mononucleosis. J Infect 25: 39–46, 1992. [DOI] [PubMed] [Google Scholar]
  • 12. Gutiérrez J, Maroto C, Piédrola G: Evaluation of a new reagent for anti‐Cytomegalovirus and anti‐Epstein‐Barr virus IgG. J Clin Microbiol 32: 2603–2605, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Blackburn NK, Besselaar TG, Schoub BD, O'Connell KF: Differentiation of primary Cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J Med Virol 33: 6–9, 1991. [DOI] [PubMed] [Google Scholar]
  • 14. Hedman K, Vaheri A, Brumemmer‐Korvenkontio M: Rapid diagnosis of Hantavirus disease with an IgG‐avidity assay. Lancet 338: 1353–1356, 1991. [DOI] [PubMed] [Google Scholar]
  • 15. Meurman O, Waris M, Hedman K: Immunoglobulin G antibody avidity in patients with respiratory syncitial virus infection. J Clin Microbiol 30: 1479–1484, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Schoub BD, Blackburn NK, Jhonson S, McAnerney JM, Miller B: Low antibody avidity in elderly chickenpox patients. J Med Virol 37: 113–115, 1992. [DOI] [PubMed] [Google Scholar]
  • 17. Thomas HIJ, Morgan‐Capner P, Enders G, O'Shea S, Calicott D, Best JM: Persistence of specific IgM and low avidity specific IgGl following primary rubella. J Virolog Meth 39: 149–155, 1992. [DOI] [PubMed] [Google Scholar]
  • 18. Chen HA, Jhonson BD, Sims TJ, Darveau RP, Moncla BJ, Whitney CW, Engel D, Page RC: Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients. J Periodontol 2: 781–791, 1991. [DOI] [PubMed] [Google Scholar]
  • 19. Guigno D, Coupland B, Smith EG, Farrell ID, Desselberger U, Caul EO: Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever. J Clin Microbiol 30: 1958–1967, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Lahesmaa‐Rantala R, Lehtonen O, Granfors K, Toivaven A: Avidity of anti‐yersinia antibodies in yersiniosis patients with and without yersinia triggered reactive arthritis. Arthr Rheumatism 30: 1176–1180, 1987. [DOI] [PubMed] [Google Scholar]
  • 21. Lopatin DE, LaBelle D, Lee SW: Measurement of relative avidity of antibodies reactive with Porphyromonas (Bacteroides) gingivalis in the sera of subjects having adult periodontitis. J Periodont Res 26: 167–175, 1991. [DOI] [PubMed] [Google Scholar]
  • 22. Maes RF: Evaluation of avidity of IgG anti‐mycobacterial antibodies in tuberculous patients serum by an A‐60 immunoassay. Eur J Epidemiol 7: 188–90, 1991. [DOI] [PubMed] [Google Scholar]
  • 23. Thomas HIJ, Morgan‐Capner P, Connor NS: Adaptation of a commercial rubella‐specific IgG to assess specific IgG avidity: Serodiagn. Immunother Infect Dis 1: 13–16, 1993. [Google Scholar]
  • 24. Thomas HIJ, Morgan‐Capner P, Cradeck‐Watson JE, Enders G, Best JM, O'Shea S: Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: Implications for diagnosis and immunopathology. J Med Virol 41: 196–200, 1993. [DOI] [PubMed] [Google Scholar]
  • 25. Lappalainen M, Koskela P, Koskiniemi M, Ammálá P, Hiilesmaa V, Teramo K, Raivio KO, Remington JS, Hedman K: Toxoplasmosis acquired during pregnancy: Improved serodiagnosis based on avidity of IgG. J Infect Dis 167: 691–697, 1993. [DOI] [PubMed] [Google Scholar]
  • 26. Joynson DHM, Payne RA, Rawal BK: Potential role of IgG avidity for diagnosing toxoplasmosis. J Clin Pathol 43: 1032–1033, 1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Kangro HO, Manzoor S, Harper DR: Antibody avidity following varicella‐zoster virus infections. J Med Virol 33: 100–105, 1991. [DOI] [PubMed] [Google Scholar]
  • 28. Anderson A, Vetter V, Kreutzer L, Bauer G: Avidities of IgG directed against viral capsid antigen or early antigen: Useful markers for significant Epstein‐Barr virus serology. J Med Virol 43: 238–244, 1994. [DOI] [PubMed] [Google Scholar]
  • 29. Gorgievski‐Hrisoho M, Hinderer W, Nebel‐Schickel H: Serodiagnosis of infectious mononucleosis by using recombinant Epstein‐Barr virus antigens and enzyme linked immunosorbent assay technology. J Clin Microbiol 28: 2305–2311, 1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. De Ory F: Contribution to diagnosis and epidemiology of infections by Epstein Barr virus, Cytomegalovirus and Herpes Virus Human type 6. University Complutense from Madrid, doctoral thesis, 1994.
  • 31. Linde A: Diagnosis and pathogenesis of infectious mononucleosis and other Epstein Barr virus associated diseases. Rev Med Microbiol 3: 43–51, 1992. [Google Scholar]
  • 32. Gutiérrez J, Piédrola G, Maroto C: Acute infection due to Epstein‐Barr virus. Comparative study among diverse diagnostics methods. Rev Clin Esp 191: 305–307, 1992. [PubMed] [Google Scholar]
  • 33. Wiedbrauk DL, Bassin S: Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein‐Barr virus viral capsid antigens. J Clin Microbiol 31: 1339–1341, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES